Time slot's time in Taipei (GMT+8)
2025/11/21 14:00-17:30 Room 201 ABC
- Kick-on Seminar VII
Artificial Intelligence (AI): The Roadmap for Precision Medicine and Individualized Management
- Time
- Topic
- Speaker
- Moderator
- 17:00-17:30
- Transforming Stroke Medicine: The Emerging Role of AI in Early Detection and Prognosis
- Speaker:
Wei-Chun Wang
(Taiwan)
- Moderator:
Lung Chan
(Taiwan)
- Lung Chan
- MD, PhD
-
Vice Superintendent, Taipei Medical University-Shuang Ho Hospital
Professor, Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University
President, Taiwan Stroke Society
E-mail：cjustinmd@gmail.com
Executive Summary：
Dr. Lung Chan is a distinguished neurologist and healthcare leader based in Taiwan. He currently serves as Vice Superintendent of Taipei Medical University - Shuang Ho Hospital and President of the Taiwan Stroke Society. With over two decades of clinical and academic experience, Dr. Chan has made significant contributions in the fields of cerebrovascular disease, neuro-critical care, and neurosonology.
Dr. Chan earned his medical degree from China Medical University and subsequently pursued advanced degrees in public health and health education, obtaining a Master of Science from Fu Jen Catholic University and a PhD from National Taiwan Normal University. His multidisciplinary training underpins his holistic approach to patient care and healthcare system improvement.
He holds a professorship in the Department of Neurology at Taipei Medical University’s School of Medicine, where he is actively involved in teaching and mentoring. Throughout his career, Dr. Chan has led several key hospital departments including Neurology, Medical Quality, and the Stroke Center, playing a pivotal role in enhancing clinical services and integrating diagnostics and therapeutics.
Dr. Chan has also contributed to national neurological and stroke care policy through leadership roles in professional societies, including the Taiwan Stroke Association and the Taiwan Neuro-Critical Care Society. His work reflects a deep commitment to advancing stroke prevention, acute care, and rehabilitation across the region.
Respected for his expertise, vision, and leadership, Dr. Lung Chan continues to shape the future of stroke medicine and neurocritical care in Taiwan and beyond.
Dr. Lung Chan is a distinguished neurologist and healthcare leader based in Taiwan. He currently serves as Vice Superintendent of Taipei Medical University - Shuang Ho Hospital and President of the Taiwan Stroke Society. With over two decades of clinical and academic experience, Dr. Chan has made significant contributions in the fields of cerebrovascular disease, neuro-critical care, and neurosonology.
Dr. Chan earned his medical degree from China Medical University and subsequently pursued advanced degrees in public health and health education, obtaining a Master of Science from Fu Jen Catholic University and a PhD from National Taiwan Normal University. His multidisciplinary training underpins his holistic approach to patient care and healthcare system improvement.
He holds a professorship in the Department of Neurology at Taipei Medical University’s School of Medicine, where he is actively involved in teaching and mentoring. Throughout his career, Dr. Chan has led several key hospital departments including Neurology, Medical Quality, and the Stroke Center, playing a pivotal role in enhancing clinical services and integrating diagnostics and therapeutics.
Dr. Chan has also contributed to national neurological and stroke care policy through leadership roles in professional societies, including the Taiwan Stroke Association and the Taiwan Neuro-Critical Care Society. His work reflects a deep commitment to advancing stroke prevention, acute care, and rehabilitation across the region.
Respected for his expertise, vision, and leadership, Dr. Lung Chan continues to shape the future of stroke medicine and neurocritical care in Taiwan and beyond.
